Realm Therapeutics PLC, a U.K. developer of topical medicines for skin conditions, is listing its American depositary shares on the Nasdaq Stock Market.
The ADSs will begin trading this month under the ticker RLM.
The London-based company will list 126,857,901 ordinary shares, represented by about 5,074,316 ADSs. Each ADS represents 25 ordinary shares, with a nominal value of 10 pence per share.
Realm said it will not receive proceeds from the transaction.